Ideas For Profit Dollar & Rupa: Value innerwear stocks to outperform despite COVID-led disruptions

Value innerwear players, Dollar Industries and Rupa & Company, posted strong double-digit earnings growth YoY in Q2FY22. Volume growth on account of increased demand, following the unlocking measures as well as price hikes, helped deliver earnings growth. Also, given the essential nature of the segment, it is likely to outperform in a scenario of lockdowns or restrictions, if there is a third wave of COVID-19. Any weakness in the stock price would be an opportunity to add both Dollar and Rupa in the portfolio. Watch the video to find out which stock you should bet on.
Value innerwear players, Dollar Industries and Rupa & Company, posted strong double-digit earnings growth YoY in Q2FY22. Volume growth on account of increased demand, following the unlocking measures as well as price hikes, helped deliver earnings growth. Also, given the essential nature of the segment, it is likely to outperform in a scenario of lockdowns or restrictions, if there is a third wave of COVID-19. Any weakness in the stock price would be an opportunity to add both Dollar and Rupa in the portfolio. Watch the video to find out which stock you should bet on.

ROP.N -, Stock Price & Latest News

Walmart (WMT) Profit Warning Underlines Shift in Consumer Spending

ICICI Securities Share Market, About the company

Apparel

Amid coronavirus, Walmart says it's seeing increased sales of tops

Rupa & Co, Dollar Ind, Kitex Garments hit 52-wk lows on weak Q3

Ideas For Profit Dollar & Rupa: Value innerwear stocks to outperform despite COVID-led disruptions

33 Undervalued Stocks for Q1: Morningstar, 2024

3 Power Stocks Ready to Ride the Market's Upward Wave

14 Profit-Making Stocks to Buy, Including One With 181% Upside: BofA

Nasdaq posts higher fourth-quarter profit on strength in fintech

Future of retail: Experts see innovation and pop-up stores

How 2020 Accelerated Currency Trends and What's Ahead

Inflation: Why Jockey, Lux, Rupa still hold an invisible pull

Moderna: Shares Remain Deeply Undervalued, Despite Our Lower COVID